Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Kiora Pharmaceuticals, Inc. has received grant funding from the Choroideremia Research Foundation in support of validating functional vision assessments for patients with profound blindness....
Source: marketscreener.com
